Inclusion Criteria:  Age 18 through 25 years Body Mass Index ≥ 25 Kg/m2  Exclusion Criteria:  Reported habitual dietary intake of C15:0 that consistently exceeds 250 mg per day Significant alcohol consumption (average consumption >1 drink/day for females, >2 drink/day for males or episodes of binge drinking >5 drinks/day) Inability to swallow capsules Type 1 or Type 2 Diabetes Liver Cirrhosis Pregnancy Body weight greater than 125 kg at screening LDL-cholesterol > 160 mg/dL Triglycerides > 500 mg/dL Hemoglobin < 10.0 gm/dL Current Omega 3 Fatty Acid supplement usage Current use of Statin medications Any other condition which, in the opinion of the investigator, would impede compliance or hinder completion of the study Patients who are currently enrolled in a clinical trial or who received an investigational study drug within 180 days of screening. Subjects who are not able or willing to comply with the protocol or have any other condition that would impede compliance or hinder completion of the study, in the opinion of the investigator. Failure to give informed consent